APRIL is overexpressed in cancer: Link with tumor progression

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Moreaux, Jérôme ^a   Veyrune, Jean Luc ^a,b   De Vos, John ^a,b,c   Klein, Bernard ^a,b,c  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; B CELL ACTIVATING FACTOR RECEPTOR; PROTEOHEPARAN SULFATE; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR; BIS(3 BIS(4 CHLOROPHENYL)METHYL 4 DIMETHYLAMINOPHENYL)AMINE; BIS(3-BIS(4-CHLOROPHENYL)METHYL-4-DIMETHYLAMINOPHENYL)AMINE; DIPHENYLAMINE; DRUG DERIVATIVE; HEPARIN; HEPARIN PROTEOGLYCAN; PROTEOGLYCAN; TNFRSF13B PROTEIN, HUMAN; TNFSF13B PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; ASTROCYTOMA; BLADDER CARCINOMA; BREAST CANCER; CANCER STAGING; CARCINOGENESIS; CLEAR CELL CARCINOMA; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC DATABASE; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; LYMPHOMA; MULTIPLE MYELOMA; PROGNOSIS; SOLID TUMOR; THYROID CARCINOMA; UTERINE CERVIX CARCINOMA; B LYMPHOCYTE; CARCINOMA; CELL PROLIFERATION; CELL SURVIVAL; DISEASE COURSE; DNA MICROARRAY; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY; PROTEIN BINDING; THYROID TUMOR;

B-CELL ACTIVATING FACTOR; B-CELL ACTIVATION FACTOR RECEPTOR; B-LYMPHOCYTES; CARCINOMA; CELL PROLIFERATION; CELL SURVIVAL; DIPHENYLAMINE; DISEASE PROGRESSION; HEPARIN; HUMANS; LYMPHOMA; MULTIPLE MYELOMA; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROTEIN BINDING; PROTEOGLYCANS; THYROID NEOPLASMS; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR PROTEIN; TUMOR MARKERS, BIOLOGICAL; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13;

EID: 63849239722     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-83     Document Type: Article

References (73)

1. Nardelli B Belvedere O Roschke V Moore PA Olsen HS Migone TS Sosnovtseva S Carrell JA Feng P Giri JG et al Synthesis and release of B-lymphocyte stimulator from myeloid cells Blood 2001, 97(1):198-204. 10.1182/ blood.V97.1.198 11133761
2. Schneider P MacKay F Steiner V Hofmann K Bodmer JL Holler N Ambrose C Lawton P Bixler S Acha-Orbea H et al BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth J Exp Med 1999, 189(11):1747-1756. 2193079 10359578 10.1084/jem.189.11.1747
3. Lopez-Fraga M Fernandez R Albar JP Hahne M Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase EMBO Rep 2001, 2(10):945-951. 1084076 11571266 10.1093/ embo-reports/kve198
4. Kolfschoten GM Pradet-Balade B Hahne M Medema JP TWE-PRIL; a fusion protein of TWEAK and APRIL Biochem Pharmacol 2003, 66(8):1427-1432. 10.1016/S0006-2952(03)00493-3 14555217
5. Pradet-Balade B Medema JP Lopez-Fraga M Lozano JC Kolfschoten GM Picard A Martinez AC Garcia-Sanz JA Hahne M An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion protein Embo J 2002, 21(21):5711-5720. 131062 12411489 10.1093/emboj/cdf565
6. Avery DT Kalled SL Ellyard JI Ambrose C Bixler SA Thien M Brink R Mackay F Hodgkin PD Tangye SG BAFF selectively enhances the survival of plasmablasts generated from human memory B cells J Clin Invest 2003, 112(2):286-297. 164292 12865416
7. Bossen C Cachero TG Tardivel A Ingold K Willen L Dobles M Scott ML Maquelin A Belnoue E Siegrist CA et al TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts Blood 2008, 111(3):1004-1012. 10.1182/ blood-2007-09-110874 17942754
8. Mackay F Schneider P Rennert P Browning J BAFF AND APRIL: A Tutorial on B Cell Survival Annu Rev Immunol 2003, 21:231-264. 10.1146/ annurev.immunol.21.120601.141152 12427767
9. Hahne M Kataoka T Schroter M Hofmann K Irmler M Bodmer JL Schneider P Bornand T Holler N French LE et al APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth J Exp Med 1998, 188(6):1185-1190. 2212534 9743536 10.1084/jem.188.6.1185
10. Belnoue E Pihlgren M McGaha TL Tougne C Rochat AF Bossen C Schneider P Huard B Lambert PH Siegrist CA APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early life bone marrow stromal cells Blood 2008, 111(5):2755-2764. 10.1182/ blood-2007-09-110858 18180376
11. Huard B McKee T Bosshard C Durual S Matthes T Myit S Donze O Frossard C Chizzolini C Favre C et al APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa J Clin Invest 2008, 118(8):2887-2895. 2447926 18618015
12. Briones J Timmerman JM Hilbert DM Levy R BLyS and BLyS receptor expression in non-Hodgkin's lymphoma Exp Hematol 2002, 30(2):135-141. 10.1016/S0301-472X(01)00774-3 11823048
13. Fu L Lin-Lee YC Pham LV Tamayo A Yoshimura L Ford RJ Constitutive NF-kappaB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas Blood 2006, 107(11):4540-4548. 1895801 16497967 10.1182/blood-2005-10-4042
14. He B Chadburn A Jou E Schattner EJ Knowles DM Cerutti A Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL J Immunol 2004, 172(5):3268-3279. 14978135
15. Novak AJ Grote DM Stenson M Ziesmer SC Witzig TE Habermann TM Harder B Ristow KM Bram RJ Jelinek DF et al Expression of BLyS and Its Receptors in B-Cell Non-Hodgkin Lymphoma: Correlation With Disease Activity and Patient Outcome Blood 2004, 104(8):2247-2253. 10.1182/blood-2004-02-0762 15251985
16. Schwaller J Schneider P Mhawech-Fauceglia P McKee T Myit S Matthes T Tschopp J Donze O Le Gal FA Huard B Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness Blood 2007, 109(1):331-338. 10.1182/ blood-2006-02-001800 17190854
17. Chiu A Xu W He B Dillon SR Gross JA Sievers E Qiao X Santini P Hyjek E Lee JW et al Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL Blood 2007, 109(2):729-739. 1785096 16960154 10.1182/ blood-2006-04-015958
18. Kern C Cornuel JF Billard C Tang R Rouillard D Stenou V Defrance T Ajchenbaum-Cymbalista F Simonin PY Feldblum S et al Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway Blood 2004, 103(2):679-688. 10.1182/blood-2003-02-0540 14504101
19. Novak AJ Bram RJ Kay NE Jelinek DF Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: A mechanism for survival Blood 2002, 100(8):2973-2979. 10.1182/blood-2002-02-0558 12351410
20. Moreaux J Cremer FW Reme T Raab M Mahtouk K Kaukel P Pantesco V De Vos J Jourdan E Jauch A et al The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature Blood 2005, 106(3):1021-1030. 2408610 15827134 10.1182/blood-2004-11-4512
21. Moreaux J Hose D Jourdan M Reme T Hundemer M Moos M Robert N Moine P De Vos J Goldschmidt H et al TACI expression is associated with a mature bone marrow plasma cell signature and C-MAF overexpression in human myeloma cell lines Haematologica 2007, 92(6):803-811. 10.3324/ haematol.10574 17550853
22. Moreaux J Legouffe E Jourdan E Quittet P Reme T Lugagne C Moine P Rossi JF Klein B Tarte K BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone Blood 2004, 103(8):3148-3157. 2387243 15070697 10.1182/blood-2003-06-1984
23. Novak AJ Darce JR Arendt BK Harder B Henderson K Kindsvogel W Gross JA Greipp PR Jelinek DF Expression of BCMA, TACI, and BAFF-R in multiple myeloma: A mechanism for growth and survival Blood 2004, 103(2):689-694. 10.1182/blood-2003-06-2043 14512299
24. Yaccoby S Pennisi A Li X Dillon SR Zhan F Barlogie B Shaughnessy JD Jr Atacicept (TACI-Ig) inhibits growth of TACI(high) primary myeloma cells in SCID-hu mice and in coculture with osteoclasts Leukemia 2008, 22(2):406-413. 10.1038/sj.leu.2405048 18046446
25. Elsawa SF Novak AJ Grote DM Ziesmer SC Witzig TE Kyle RA Dillon SR Harder B Gross JA Ansell SM B-lymphocyte stimulator (BLyS) stimulates immunoglobulin production and malignant B-cell growth in Waldenstrom macroglobulinemia Blood 2006, 107(7):2882-2888. 1895377 16304043 10.1182/ blood-2005-09-3552
26. Hendriks J Planelles L de Jong-Odding J Hardenberg G Pals ST Hahne M Spaargaren M Medema JP Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation Cell Death Differ 2005, 12(6):637-648. 10.1038/sj.cdd.4401647 15846369
27. Ingold K Zumsteg A Tardivel A Huard B Steiner QG Cachero TG Qiang F Gorelik L Kalled SL Acha-Orbea H et al Identification of proteoglycans as the APRIL-specific binding partners J Exp Med 2005, 201(9):1375-1383. 2213192 15851487 10.1084/jem.20042309
28. Rennert P Schneider P Cachero TG Thompson J Trabach L Hertig S Holler N Qian F Mullen C Strauch K et al A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth J Exp Med 2000, 192(11):1677-1684. 2193103 11104810 10.1084/jem.192.11.1677
29. Bischof D Elsawa SF Mantchev G Yoon J Michels GE Nilson A Sutor SL Platt JL Ansell SM von Bulow G et al Selective activation of TACI by syndecan-2 Blood 2006, 107(8):3235-3242. 1895754 16357320 10.1182/ blood-2005-01-0256
30. Rhodes DR Yu J Shanker K Deshpande N Varambally R Ghosh D Barrette T Pandey A Chinnaiyan AM Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression Proc Natl Acad Sci USA 2004, 101(25):9309-9314. 438973 15184677 10.1073/pnas.0401994101
31. Assou S Le Carrour T Tondeur S Strom S Gabelle A Marty S Nadal L Pantesco V Reme T Hugnot JP et al A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas Stem Cells 2007, 25(4):961-973. 1906587 17204602 10.1634/ stemcells.2006-0352
32. Rhodes DR Yu J Shanker K Deshpande N Varambally R Ghosh D Barrette T Pandey A Chinnaiyan AM ONCOMINE: A cancer microarray database and integrated data-mining platform Neoplasia (New York, NY) 2004, 6(1):1-6.
33. Brune V Tiacci E Pfeil I Doring C Eckerle S van Noesel CJ Klapper W Falini B von Heydebreck A Metzler D et al Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis J Exp Med 2008, 205(10):2251-2268. 10.1084/ jem.20080809 18794340
34. Bredel M Bredel C Juric D Harsh GR Vogel H Recht LD Sikic BI Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas Cancer Res 2005, 65(19):8679-8689. 10.1158/0008-5472.CAN-05-1204 16204036
35. French PJ Swagemakers SM Nagel JH Kouwenhoven MC Brouwer E Spek van der P Luider TM Kros JM Bent van den MJ Sillevis Smitt PA Gene expression profiles associated with treatment response in oligodendrogliomas Cancer Res 2005, 65(24):11335-11344. 10.1158/0008-5472.CAN-05-1886 16357140
36. Sun L Hui AM Su Q Vortmeyer A Kotliarov Y Pastorino S Passaniti A Menon J Walling J Bailey R et al Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain Cancer Cell 2006, 9(4):287-300. 10.1016/j.ccr.2006.03.003 16616334
37. Liang Y Diehn M Watson N Bollen AW Aldape KD Nicholas MK Lamborn KR Berger MS Botstein D Brown PO et al Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme Proc Natl Acad Sci USA 2005, 102(16):5814-5819. 556127 15827123 10.1073/ pnas.0402870102
38. Krumbholz M Theil D Derfuss T Rosenwald A Schrader F Monoranu CM Kalled SL Hess DM Serafini B Aloisi F et al BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma J Exp Med 2005, 201(2):195-200. 2212784 15642740 10.1084/ jem.20041674
39. Tschen SI Stohlman SA Ramakrishna C Hinton DR Atkinson RD Bergmann CC CNS viral infection diverts homing of antibody-secreting cells from lymphoid organs to the CNS Eur J Immunol 2006, 36(3):603-612. 10.1002/ eji.200535123 16437540
40. Richardson AL Wang ZC De Nicolo A Lu X Brown M Miron A Liao X Iglehart JD Livingston DM Ganesan S X chromosomal abnormalities in basal-like human breast cancer Cancer Cell 2006, 9(2):121-132. 10.1016/ j.ccr.2006.01.013 16473279
41. Hao Y Triadafilopoulos G Sahbaie P Young HS Omary MB Lowe AW Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma Gastroenterology 2006, 131(3):925-933. 2575112 16952561 10.1053/j.gastro.2006.04.026
42. Lenburg ME Liou LS Gerry NP Frampton GM Cohen HT Christman MF Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data BMC cancer 2003, 3:31. 317310 14641932 10.1186/1471-2407-3-31
43. Korkola JE Houldsworth J Chadalavada RS Olshen AB Dobrzynski D Reuter VE Bosl GJ Chaganti RS Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors Cancer Res 2006, 66(2):820-827. 10.1158/0008-5472.CAN-05-2445 16424014
44. Blaveri E Simko JP Korkola JE Brewer JL Baehner F Mehta K Devries S Koppie T Pejavar S Carroll P et al Bladder cancer outcome and subtype classification by gene expression Clin Cancer Res 2005, 11(11):4044-4055. 10.1158/1078-0432.CCR-04-2409 15930339
45. Sanchez-Carbayo M Socci ND Lozano J Saint F Cordon-Cardo C Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays J Clin Oncol 2006, 24(5):778-789. 10.1200/JCO.2005.03.2375 16432078
46. Kimchi ET Posner MC Park JO Darga TE Kocherginsky M Karrison T Hart J Smith KD Mezhir JJ Weichselbaum RR et al Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation Cancer Res 2005, 65(8):3146-3154. 15833844
47. Ginos MA Page GP Michalowicz BS Patel KJ Volker SE Pambuccian SE Ondrey FG Adams GL Gaffney PM Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck Cancer Res 2004, 64(1):55-63. 10.1158/0008-5472.CAN-03-2144 14729608
48. Toruner GA Ulger C Alkan M Galante AT Rinaggio J Wilk R Tian B Soteropoulos P Hameed MR Schwalb MN et al Association between gene expression profile and tumor invasion in oral squamous cell carcinoma Cancer genetics and cytogenetics 2004, 154(1):27-35. 10.1016/ j.cancergencyto.2004.01.026
49. Alizadeh AA Eisen MB Davis RE Ma C Lossos IS Rosenwald A Boldrick JC Sabet H Tran T Yu X et al Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling Nature 2000, 403(6769):503-511. 10.1038/35000501 10676951
50. Rosenwald A Wright G Chan WC Connors JM Campo E Fisher RI Gascoyne RD Muller-Hermelink HK Smeland EB Giltnane JM et al The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma N Engl J Med 2002, 346(25):1937-1947. 10.1056/ NEJMoa012914 12075054
51. Iacobuzio-Donahue CA Maitra A Olsen M Lowe AW van Heek NT Rosty C Walter K Sato N Parker A Ashfaq R et al Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays Am J Pathol 2003, 162(4):1151-1162. 1851213 12651607
52. Freije WA Castro-Vargas FE Fang Z Horvath S Cloughesy T Liau LM Mischel PS Nelson SF Gene expression profiling of gliomas strongly predicts survival Cancer Res 2004, 64(18):6503-6510. 10.1158/ 0008-5472.CAN-04-0452 15374961
53. Modlich O Prisack HB Pitschke G Ramp U Ackermann R Bojar H Vogeli TA Grimm MO Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: Use of cDNA array analysis of gene expression profiles Clin Cancer Res 2004, 10(10):3410-3421. 10.1158/1078-0432.CCR-03-0134 15161696
54. Farmer P Bonnefoi H Becette V Tubiana-Hulin M Fumoleau P Larsimont D Macgrogan G Bergh J Cameron D Goldstein D et al Identification of molecular apocrine breast tumours by microarray analysis Oncogene 2005, 24(29):4660-4671. 10.1038/sj.onc.1208561 15897907
55. Ginestier C Cervera N Finetti P Esteyries S Esterni B Adelaide J Xerri L Viens P Jacquemier J Charafe-Jauffret E et al Prognosis and gene expression profiling of 20q13-amplified breast cancers Clin Cancer Res 2006, 12(15):4533-4544. 10.1158/1078-0432.CCR-05-2339 16899599
56. Bachtiary B Boutros PC Pintilie M Shi W Bastianutto C Li JH Schwock J Zhang W Penn LZ Jurisica I et al Gene expression profiling in cervical cancer: An exploration of intratumor heterogeneity Clin Cancer Res 2006, 12(19):5632-5640. 10.1158/1078-0432.CCR-06-0357 17020965
57. Mhawech-Fauceglia P Kaya G Sauter G McKee T Donze O Schwaller J Huard B The source of APRIL up-regulation in human solid tumor lesions J Leukoc Biol 2006, 80(4):697-704. 10.1189/jlb.1105655 16793914
58. Mhawech-Fauceglia P Allal A Odunsi K Andrews C Herrmann FR Huard B Role of the tumour necrosis family ligand APRIL in solid tumour development: Retrospective studies in bladder, ovarian and head and neck carcinomas Eur J Cancer 2008, 44(15):2097-2100. 10.1016/j.ejca.2008.07.007 18718755
59. Moreaux J Sprynski A-C Mahtouk K Moine P Robert N Rossi J-F Klein B Binding of TACI and APRIL to Syndecan-1 Confer on Them a Major Role in Multiple Myeloma ASH Annual Meeting Abstracts 2007, 110(11):3522.
60. Zhan F Barlogie B Arzoumanian V Huang Y Williams DR Hollmig K Pineda-Roman M Tricot G van Rhee F Zangari M et al Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis Blood 2007, 109(4):1692-1700. 1794073 17023574 10.1182/blood-2006-07-037077
61. Huang Y Prasad M Lemon WJ Hampel H Wright FA Kornacker K LiVolsi V Frankel W Kloos RT Eng C et al Gene expression in papillary thyroid carcinoma reveals highly consistent profiles Proc Natl Acad Sci USA 2001, 98(26):15044-15049. 64980 11752453 10.1073/pnas.251547398
62. Dave SS Fu K Wright GW Lam LT Kluin P Boerma EJ Greiner TC Weisenburger DD Rosenwald A Ott G et al Molecular diagnosis of Burkitt's lymphoma N Engl J Med 2006, 354(23):2431-2442. 10.1056/NEJMoa055759 16760443
63. Gupta M Ansell SM Witzig TE Ziesmer SC Cerhan JR Dillon SR Novak AJ APRIL-TACI Interactions Mediate Non-Hodgkin Lymphoma B Cell Proliferation through Akt Regulated Cyclin D1 and P21 ASH Annual Meeting Abstracts 2007, 110(11):3585.
64. Deshayes F Lapree G Portier A Richard Y Pencalet P Mahieu-Caputo D Horellou P Tsapis A Abnormal production of the TNF-homologue APRIL increases the proliferation of human malignant glioblastoma cell lines via a specific receptor Oncogene 2004, 23(17):3005-3012. 10.1038/ sj.onc.1207350 14691452
65. Okano H Shiraki K Yamanaka Y Inoue H Kawakita T Saitou Y Yamaguchi Y Enokimura N Ito K Yamamoto N et al Functional expression of a proliferation-related ligand in hepatocellular carcinoma and its implications for neovascularization World J Gastroenterol 2005, 11(30):4650-4654. 16094704
66. Couchman JR Syndecans: Proteoglycan regulators of cell-surface microdomains? Nat Rev Mol Cell Biol 2003, 4(12):926-93.7 10.1038/nrm1257 14685171
67. Filmus J Glypicans in growth control and cancer Glycobiology 2001, 11(3):19R-23R. 10.1093/glycob/11.3.19R 11320054
68. Mahtouk K Cremer FW Reme T Jourdan M Baudard M Moreaux J Requirand G Fiol G De Vos J Moos M et al Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma Oncogene 2006, 25(54):7180-7191. 2396200 16732320 10.1038/sj.onc.1209699
69. Bernfield M Gotte M Park PW Reizes O Fitzgerald ML Lincecum J Zako M Functions of cell surface heparan sulfate proteoglycans Annu Rev Biochem 1999, 68:729-777. 10.1146/annurev.biochem.68.1.729 10872465
70. Sasisekharan R Shriver Z Venkataraman G Narayanasami U Roles of heparan-sulphate glycosaminoglycans in cancer Nat Rev Cancer 2002, 2(7):521-528. 10.1038/nrc842 12094238
71. Timar J Lapis K Dudas J Sebestyen A Kopper L Kovalszky I Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer Semin Cancer Biol 2002, 12(3):173-186. 10.1016/ S1044-579X(02)00021-4 12083848
72. Alexander CM Reichsman F Hinkes MT Lincecum J Becker KA Cumberledge S Bernfield M Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice Nat Genet 2000, 25(3):329-332. 10.1038/77108 10888884
73. Klerk CP Smorenburg SM Otten HM Lensing AW Prins MH Piovella F Prandoni P Bos MM Richel DJ van Tienhoven G et al The effect of low molecular weight heparin on survival in patients with advanced malignancy J Clin Oncol 2005, 23(10):2130-2135. 10.1200/JCO.2005.03.134 15699479